iifl-logo

Lincoln Pharmaceuticals Ltd Dividend

537.3
(-1.21%)
Sep 26, 2025|12:00:00 AM

Lincoln Pharma. CORPORATE ACTIONS

30/09/2024calendar-icon
30/09/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend22 May 202512 Sep 202512 Sep 20251.818Final
Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity shares of face value 10/- each for the Financial year Ended 31st March, 2025 subject to approval of the members at the ensuing A.G.M of the Company. The Intimation of Book Closure and Record Date is as enclosed. (As Per BSE Announcement Dated on: 29/08/2025)

Lincoln Pharma.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.